Global type 2 diabetes market to almost double to $58.7 billion by 2025; Report

The global type 2 diabetes market is set to almost double from $31.2 billion in 2015 to $58.7 billion by 2025, representing a compound annual growth rate (CAGR) of 6.5%.

According to research and consulting firm GlobalData’s latest report, this growth, which will occur across the nine major markets of the USA, France, Germany, Italy, Spain, the UK, Japan, China, and India, will primarily be attributable to a dramatic increase in the diagnosis and prevalence of the disease, and the fact that the rise in type 2 diabetes-related co-morbidities has fueled a more aggressive approach in treatment and the use of multiple-drug therapies.

Jesus Cuaron, GlobalData’s analyst covering cardiovascular and metabolic disorders, explains: “Increases in disease incidences will result from increased life expectancy and lifestyle changes, such as dietary changes and a reduction in exercise. Indeed, the US will be impacted the most by such changes, increasing its global market share from 58% to 66% during the forecast period.”